U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Class Status: Active
Name | Laurence Rickles TEVA PHARMACEUTICALS USA, INC. |
---|---|
Address | 400 INTERPACE PARKWAY BUILDING A PARSIPPANY, NJ 07054 United States |
Date | Description | Action Tags | Code |
---|---|---|---|
Apr-09-2022 | NEW APPLICATION ENTERED | NWAPI | |
Apr-11-2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Sep-20-2022 | ASSIGNED TO EXAMINER | DOCKD | |
Sep-26-2022 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAP | |
Oct-12-2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
Nov-01-2022 | PUBLISHED FOR OPPOSITION | PUBOA | |
Nov-01-2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
Nov-21-2022 | EXTENSION OF TIME TO OPPOSE RECEIVED | ETOFT | |
Dec-15-2022 | TEAS PETITION TO AMEND BASIS RECEIVED | TPADI | |
Dec-15-2022 | POST PUBLICATION AMENDMENT RECEIVED | PPARI | |
Jan-10-2023 | ASSIGNED TO PETITION STAFF | APETA | |
Jan-11-2023 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | ETOPT | |
Jan-13-2023 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | CHPBI | |
Feb-28-2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | NOAME | |
Aug-16-2023 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
Aug-16-2023 | SOU EXTENSION 1 FILED | EXT1S | |
Aug-16-2023 | SOU EXTENSION 1 GRANTED | EX1GS | |
Aug-18-2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Feb-27-2024 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
Feb-27-2024 | SOU EXTENSION 2 FILED | EXT2S | |
Feb-27-2024 | SOU EXTENSION 2 GRANTED | EX2GS | |
Feb-28-2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Aug-19-2024 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
Aug-19-2024 | SOU EXTENSION 3 FILED | EXT3S | |
Aug-19-2024 | SOU EXTENSION 3 GRANTED | EX3GS | |
Aug-19-2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE |